Covered recipient · General Payments record
BRITTANY WILLIAMS
Physician Assistants & Advanced Practice Nursing Providers Physician Assistant
General Payments · PY2022–2024
$1,267.34
- Reported across 39 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $590.38 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $185.19 | 9 |
| Acerta Pharma LLC | $158.53 | 2 |
| Bolton Medical Inc | $146.94 | 1 |
| Terumo Medical Corporation | $44.31 | 1 |
| Abbott Laboratories | $19.15 | 1 |
| Lilly USA, LLC | $18.94 | 1 |
| ABBVIE INC. | $17.32 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $19.15 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125363382 | CMS |
| ABBVIE INC. | $17.32 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108414090 | CMS |
| AstraZeneca Pharmaceuticals LP | $137.26 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105671081 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.27 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104314636 | CMS |
| Bolton Medical Inc | $146.94 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150756136 | CMS |
| Lilly USA, LLC | $18.94 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135592080 | CMS |
| Novo Nordisk Inc | $11.85 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100548274 | CMS |
| Novo Nordisk Inc | $16.99 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100564230 | CMS |
| Novo Nordisk Inc | $6.33 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100549600 | CMS |
| Novo Nordisk Inc | $0.49 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100617234 | CMS |
| Novo Nordisk Inc | $6.37 | 03/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100230072 | CMS |
| Novo Nordisk Inc | $8.03 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100355024 | CMS |
| Novo Nordisk Inc | $20.08 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100330040 | CMS |
| Novo Nordisk Inc | $110.91 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100518811 | CMS |
| Novo Nordisk Inc | $4.14 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100456898 | CMS |
| Terumo Medical Corporation | $44.31 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151773499 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.